Health AI News

All

1. Elon Musk: Grok Bot can research local doctors and call to book appointments — personal assistants start placing calls

   When agents dial booking lines, clinics need bot-call detection and callback playbooks or peak hours get messier.

   @elonmusk5,085 likes · 736 reposts · 1,088 replies · 1,208,760 viewsView post

   ExpandCollapseElon Musk: Grok Bot can research local doctors and call to book appointments — personal assistants start placing calls

   Elon Musk posted that Grok @Bot can research the best doctors in your area and phone them to book an appointment. The same day he urged users to ask Bot to make calls and likened it to a highly competent colleague. This is product promotion without published success rates, geography or medical-compliance boundaries; real bookings still depend on clinic pickup and local rules. For people and small clinics, more missed/answered calls may come from AI rather than humans.

2. Eric Topol: exercise should be prescribed, not just advised — for brain health

   If “exercise prescriptions” enter primary care and checkup products, vendors need actionable dose and follow-up—not “walk more.”

   @EricTopol654 likes · 159 reposts · 29 replies · 48,099 viewsView post

   ExpandCollapseEric Topol: exercise should be prescribed, not just advised — for brain health

   Physician-scientist Eric Topol stressed that exercise for brain health should be prescribed, not merely advised, linking related review/commentary and a graphic. The post is advocacy; dosing, indications and contraindications follow the linked literature—not a full new RCT readout. It shows clinical KOLs pushing lifestyle interventions toward a prescribe-able narrative akin to drugs.

3. Eric Topol: noninvasive vagus-nerve modulation may hold Parkinson’s potential — Nature BME experimental-model work

   When experimental models trend, clinic buyers must check human trials and device clearance—don’t treat preprint buzz as therapy.

   @EricTopol198 likes · 40 reposts · 9 replies · 18,138 viewsView post

   ExpandCollapseEric Topol: noninvasive vagus-nerve modulation may hold Parkinson’s potential — Nature BME experimental-model work

   Eric Topol urged not underestimating vagus-nerve modulation and linked Nature Biomedical Engineering work on a noninvasive approach with Parkinson’s potential in experimental models. He frames it as experimental-model research, not an approved therapy. For neuromodulation and digital-health teams, mechanism exploration remains hot—but patient-endpoint translation still needs rigorous trials.

4. Eric Topol: Utah leads U.S. consumer health-AI pilots — yet no peer-reviewed papers; some sell their own products end-to-end

   Fast pilot approvals ≠ clinical evidence; buyers should demand papers and conflict disclosures before press releases.

   @EricTopol39 likes · 10 reposts · 15 replies · 11,715 viewsView post

   ExpandCollapseEric Topol: Utah leads U.S. consumer health-AI pilots — yet no peer-reviewed papers; some sell their own products end-to-end

   Eric Topol’s critical note: Utah leads the U.S. in approving consumer health-AI company pilots, yet none have published peer-reviewed papers, and one sells its own proprietary products inside an “end-to-end” AI healthcare offer. Screenshot/press-linked advocacy highlighting evidence gaps and conflict risk—not a regulatory enforcement action.

5. Mistral: Large 4 writes a quantum-chemistry SCF solver from a short prompt and builds 3D visualization — early drug/materials compute

   Early R&D compute is becoming short-promptable—drug and materials teams still need in-house validation sets, not demos as SOPs.

   @MistralAI1,326 likes · 123 reposts · 137 replies · 55,760 viewsView post

   ExpandCollapseMistral: Large 4 writes a quantum-chemistry SCF solver from a short prompt and builds 3D visualization — early drug/materials compute

   Mistral showed Mistral Large 4 writing a quantum-chemistry self-consistent-field (SCF) solver from a short prompt, validating outputs and building a 3D view of orbital changes when a molecule is broken apart. Follow-ups frame SCF as how chemists predict molecular behavior on a computer before lab work—toward drugs, materials or batteries. Official demo without independent benchmarks or production-deployment data; treat as a capability showcase, not a ready pharma pipeline tool.